Literature DB >> 32920971

Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Hiroshi Deguchi1, Shravan Morla1, John H Griffin1,2.   

Abstract

Essentials Striated muscle myosins can promote prothrombin activation by FXa or FVa inactivation by APC. Cardiac myosin and skeletal muscle myosin are pro-hemostatic in murine tail cut bleeding models. Infused cardiac myosin exacerbates myocardial injury caused by myocardial ischemia reperfusion. Skeletal muscle myosin isoforms that circulate in human plasma can be grouped into 3 phenotypes. ABSTRACT: Two striated muscle myosins, namely skeletal muscle myosin (SkM) and cardiac myosin (CM), may potentially contribute to physiologic mechanisms for regulation of thrombosis and hemostasis. Thrombin is generated from activation of prothrombin by the prothrombinase (IIase) complex comprising factor Xa, factor Va, and Ca++ ions located on surfaces where these factors are assembled. We discovered that SkM and CM, which are abundant motor proteins in skeletal and cardiac muscles, can provide a surface for thrombin generation by the prothrombinase complex without any apparent requirement for phosphatidylserine or lipids. These myosins can also provide a surface that supports the inactivation of factor Va by activated protein C/protein S, resulting in negative feedback downregulation of thrombin generation. Although the physiologic significance of these reactions remains to be established for humans, substantive insights may be gleaned from murine studies. In mice, exogenously infused SkM and CM can promote hemostasis as they are capable of reducing tail cut bleeding. In a murine myocardial ischemia-reperfusion injury model, exogenously infused CM exacerbates myocardial infarction damage. Studies of human plasmas show that SkM antigen isoforms of different MWs circulate in human plasma, and they can be used to identify three plasma SkM phenotypes. A pilot clinical study showed that one SkM isoform pattern appeared to be linked to isolated pulmonary embolism. These discoveries enable multiple preclinical and clinical studies of SkM and CM, which should provide novel mechanistic insights with potential translational relevance for the roles of CM and SkM in the pathobiology of hemostasis and thrombosis.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood coagulation; factor X; myocardial infarction; myosin; prothrombinase; thrombin

Mesh:

Substances:

Year:  2020        PMID: 32920971      PMCID: PMC7819347          DOI: 10.1111/jth.15097

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  100 in total

Review 1.  Annexins as nucleotide-binding proteins: facts and speculations.

Authors:  J Bandorowicz-Pikula; R Buchet; S Pikula
Journal:  Bioessays       Date:  2001-02       Impact factor: 4.345

2.  Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.

Authors:  Valerie A Novakovic; Gary E Gilbert
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

3.  Collagen binding activity of recombinant and N-terminally modified annexin V (anchorin CII).

Authors:  J Turnay; E Pfannmüller; M A Lizarbe; W M Bertling; K von der Mark
Journal:  J Cell Biochem       Date:  1995-06       Impact factor: 4.429

Review 4.  Coagulopathy of Trauma.

Authors:  Mitchell J Cohen; S Ariane Christie
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

5.  Lactadherin promotes VEGF-dependent neovascularization.

Authors:  Jean-Sébastien Silvestre; Clotilde Théry; Ghislaine Hamard; Jacques Boddaert; Barbara Aguilar; Alain Delcayre; Christophe Houbron; Radia Tamarat; Olivier Blanc-Brude; Sylvia Heeneman; Michel Clergue; Micheline Duriez; Régine Merval; Bernard Lévy; Alain Tedgui; Sebastian Amigorena; Ziad Mallat
Journal:  Nat Med       Date:  2005-04-17       Impact factor: 53.440

6.  Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin.

Authors:  Mary J Heeb; José A Fernández; Atsuki Yamashita; Olivia R McDowell; Zihan Guo; Laurent O Mosnier; Hiroshi Deguchi; John H Griffin
Journal:  Haematologica       Date:  2019-12-19       Impact factor: 9.941

7.  Evidence of a role for lactadherin in Alzheimer's disease.

Authors:  Jacques Boddaert; Kiyoka Kinugawa; Jean-Charles Lambert; Fatiha Boukhtouche; Joffrey Zoll; Régine Merval; Olivier Blanc-Brude; David Mann; Claudine Berr; José Vilar; Béatrice Garabedian; Nathalie Journiac; Dominique Charue; Jean-Sébastien Silvestre; Charles Duyckaerts; Philippe Amouyel; Jean Mariani; Alain Tedgui; Ziad Mallat
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

8.  Molecular cloning and characterization of annexin V-binding proteins with highly hydrophilic peptide structure.

Authors:  K Ohsawa; Y Imai; D Ito; S Kohsaka
Journal:  J Neurochem       Date:  1996-07       Impact factor: 5.372

9.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

Review 10.  Polyphosphate in thrombosis, hemostasis, and inflammation.

Authors:  Catherine J Baker; Stephanie A Smith; James H Morrissey
Journal:  Res Pract Thromb Haemost       Date:  2018-11-15
View more
  3 in total

1.  Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.

Authors:  Shravan Morla; Hiroshi Deguchi; Jevgenia Zilberman-Rudenko; András Gruber; Owen J T McCarty; Priyanka Srivastava; David Gailani; John H Griffin
Journal:  J Biol Chem       Date:  2022-01-07       Impact factor: 5.157

2.  Full-length plasma skeletal muscle myosin isoform deficiency is associated with coagulopathy in acutely injured patients.

Authors:  Julia R Coleman; Hiroshi Deguchi; Taichi K Deguchi; Mitchel J Cohen; Ernest E Moore; John H Griffin
Journal:  J Thromb Haemost       Date:  2022-03-20       Impact factor: 16.036

3.  Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.

Authors:  Shravan Morla; Hiroshi Deguchi; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-12-10       Impact factor: 5.824

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.